Literature DB >> 23224450

Anhedonia in Parkinson's disease: an overview.

Gwenolé Loas1, Pierre Krystkowiak, Olivier Godefroy.   

Abstract

This article presents an overview of anhedonia, the lowered ability to experience pleasure, in Parkinson's disease (PD). The definition, measurement, relationships with depression and apathy in PD, treatment, and hyperhedonia related to impulse-control disorder are presented and discussed. The authors present the value of a more circumscribed definition of anhedonia taking into account the distinction between anticipatory and consummatory anhedonia and propose various research approaches.

Entities:  

Mesh：

Year:  2012        PMID： 23224450     DOI： 10.1176/appi.neuropsych.11110332

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


  21 in total

1.  Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson's disease.

Authors:  Zakiya Qualls; Dwayne Brown; Carlana Ramlochansingh; Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2014-01       Impact factor: 3.911

2.  [Coexistent depressive and anxiety disorders in neurological diseases: from a perspective of multimorbidity].

Authors:  H P Kapfhammer
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

3.  Assessment of Snaith-Hamilton Pleasure Scale (SHAPS): the dimension of anhedonia in Italian healthy sample.

Authors:  Iolanda Martino; Gabriella Santangelo; Daniela Moschella; Luana Marino; Rocco Servidio; Antonio Augimeri; Angela Costabile; Giovanni Capoderose; Antonio Cerasa
Journal:  Neurol Sci       Date:  2018-01-30       Impact factor: 3.307

Review 4.  Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression.

Authors:  Yena Lee; Mehala Subramaniapillai; Elisa Brietzke; Rodrigo B Mansur; Roger C Ho; Samantha J Yim; Roger S McIntyre
Journal:  Ther Adv Psychopharmacol       Date:  2018-11-19

5.  Temporal Dissociation of Striatum and Prefrontal Cortex Uncouples Anhedonia and Defense Behaviors Relevant to Depression in 6-OHDA-Lesioned Rats.

Authors:  Filipe C Matheus; Daniel Rial; Joana I Real; Cristina Lemos; Reinaldo N Takahashi; Leandro J Bertoglio; Rodrigo A Cunha; Rui D Prediger
Journal:  Mol Neurobiol       Date:  2015-07-12       Impact factor: 5.590

6.  Anhedonia and Hyperhedonia in Autism and Related Neurodevelopmental Disorders.

Authors:  Gabriel S Dichter; Jose Rodriguez-Romaguera
Journal:  Curr Top Behav Neurosci       Date:  2022

7.  Early-onset Parkinsonian behaviors in female Pink1-/- rats.

Authors:  Julia M Marquis; Samantha E Lettenberger; Cynthia A Kelm-Nelson
Journal:  Behav Brain Res       Date:  2019-09-19       Impact factor: 3.332

8.  Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS).

Authors:  Diego A Pizzagalli; Moria Smoski; Yuen-Siang Ang; Alexis E Whitton; Gerard Sanacora; Sanjay J Mathew; John Nurnberger; Sarah H Lisanby; Dan V Iosifescu; James W Murrough; Hongqiu Yang; Richard D Weiner; Joseph R Calabrese; Wayne Goodman; William Z Potter; Andrew D Krystal
Journal:  Neuropsychopharmacology       Date:  2020-06-16       Impact factor: 7.853

Review 9.  "Pseudo-syndromes" associated with Parkinson disease, dementia, apathy, anxiety, and depression.

Authors:  Howard D Weiss; Gregory M Pontone
Journal:  Neurol Clin Pract       Date:  2019-08

Review 10.  Modelling cognitive affective biases in major depressive disorder using rodents.

Authors:  Claire A Hales; Sarah A Stuart; Michael H Anderson; Emma S J Robinson
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.